Cyanotech (OTCMKTS:CYAN) Issues Quarterly Earnings Results

Cyanotech (OTCMKTS:CYAN) issued its quarterly earnings data on Tuesday. The biotechnology company reported $0.12 earnings per share for the quarter, Zacks reports. Cyanotech had a negative return on equity of 0.86% and a negative net margin of 0.25%. The company had revenue of $7.96 million for the quarter.

Cyanotech Price Performance

Shares of Cyanotech stock remained flat at $0.54 on Thursday. The stock had a trading volume of 49,624 shares, compared to its average volume of 2,121. The firm has a market capitalization of $4.14 million, a price-to-earnings ratio of -2.16 and a beta of -0.09. The company has a current ratio of 1.06, a quick ratio of 0.39 and a debt-to-equity ratio of 0.13. The firm’s 50-day simple moving average is $0.53 and its 200-day simple moving average is $0.46. Cyanotech has a 12-month low of $0.23 and a 12-month high of $0.78.

Cyanotech Company Profile

Cyanotech Corporation is a Hawaii-based producer of specialty health and nutrition products derived from microalgae. The company cultivates microalgae in open ponds at its facility on the Kona coast of Hawaii and processes the biomass into nutritional supplements and ingredient products. Its primary products include Hawaiian Spirulina Pacifica, a spirulina-based nutritional supplement, and BioAstin Hawaiian Astaxanthin, a natural antioxidant derived from the microalga Haematococcus pluvialis . Cyanotech has marketed these products for use in dietary supplements, functional foods and other health-related applications.